[O1] Oral Presentations 1

2:00 PM - 2:10 PM JST(5:00 AM - 5:10 AM UTC)R&D IImmunology

[O1-02] Development of universal off-the-shelf T cell medicine produced from pluripotent stem cells for the treatment of COVID-19

*Hiroshi Kawamoto¹ (1. Institute for Life and Medical Sciences, Kyoto University (Japan))

Password required to view

Log in

or